Pfm Health Sciences, LP Pmv Pharmaceuticals, Inc. Call Options Transaction History
Pfm Health Sciences, LP
- $1.25 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMVP
# of Institutions
63Shares Held
40.2MCall Options Held
1.8KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$5.44 Million0.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.75MShares$3.15 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$3.14 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$2.78 Million0.07% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$2.21 Million1.08% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $38.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...